Myeloproliferative Neoplasms

Top Story

Reflections on my 30th ASH Annual Meeting

Reflections on my 30th ASH Annual Meeting
HemOnc Today, January 10, 2020
John Sweetenham, MD
In the Journals

Luspatercept reduces transfusion burden for certain patients with lower-risk myelodysplastic syndrome

January 8, 2020
Luspatercept reduced the severity of anemia compared with placebo among certain patients with lower-risk myelodysplastic syndromes, according to results of a randomized…
FDA News

FDA grants orphan drug designation to PRGN-3006 for AML

January 6, 2020
The FDA granted orphan drug designation to PRGN-3006 for the treatment of relapsed or refractory acute myeloid leukemia, according to the agent’s manufacturer…

AACR-MPM Oncology Charitable Foundation awards grants to cancer researchers

January 2, 2020
American Association for Cancer Research and MPM Capital awarded two grants that will provide a combined $800,000 for cancer research. These are the first grants funded…
More Headlines »